vancomycin has been researched along with lactic acid in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.52) | 18.7374 |
1990's | 12 (18.18) | 18.2507 |
2000's | 12 (18.18) | 29.6817 |
2010's | 35 (53.03) | 24.3611 |
2020's | 6 (9.09) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Arthur, M; Bugg, TD; Courvalin, P; Molinas, C; Walsh, CT; Wright, GD | 1 |
Finegold, S; Gitlin, N; Linder, J; Mann, L; Merritt, J; Rolfe, R; Stolberg, L | 1 |
Allen, NE; Hobbs, JN | 1 |
Arthur, M; Courvalin, P; Depardieu, F; Molinas, C; Reynolds, P | 1 |
Allen, NE; Bernard, N; Delcour, J; Ferain, T; Garmyn, D; Hobbs, JN; Hols, P; Richardson, J | 1 |
Calhoun, J; Cobos, J; Mader, JT | 1 |
Calhoun, JH; Mader, JT | 1 |
Benoit, MA; Bouillet, R; Delloye, C; Gillard, J; Mousset, B | 1 |
Axelsen, PH; Li, D | 1 |
Chan, EC; Chao, EK; Chen, KT; Lin, SS; Liu, SJ; Shih, CH; Tsai, CH; Ueng, SW; Wei, FC | 1 |
Lauková, A | 1 |
Healy, VL; Lessard, IA; Park, IS; Walsh, CT | 1 |
Axelsen, PH; Kaplan, J; Loll, PJ; Selinsky, BS | 1 |
Abell, C; Cooper, MA; Fiorini, MT; Williams, DH | 1 |
Cavalletti, R; Gavazzi, C; Lodi, R; Stacchiotti, S | 1 |
Leitch, EC; Willcox, MD | 1 |
Alvarez, MG; Chetoni, P; Cossu, M; Gavini, E; Giunchedi, P; Saettone, MF | 1 |
Atilla, B; Caliş, S; Hincal, AA; Marangoz, S; Sayin, B | 1 |
Chan, EC; Chen, JK; Chi, PS; Lin, SS; Liu, SJ; Ueng, SW | 1 |
Burillon, C; Casoli-Bergeron, E; Clayer-Montembault, A; Fessi, H; Freney, J; Hachicha, W; Jaafar, C; Kodjikian, L; Lee, MY | 1 |
Daniel, R; Deghorain, M; Errington, J; Fontaine, L; Goffin, P; Hallet, B; Hols, P; Mainardi, JL | 1 |
Horáková, J; Knob, R; Maier, V; Petr, J; Sevcík, J | 1 |
Chen, HC; Govender, T; Sun, R; Xiong, CD; Xiong, ZC; Xu, L; Yang, DJ; Zhang, LF | 1 |
Dias de Castro, AC; Ferreira Gomes Leite, S; Lemos Miguel, MA | 1 |
Kau, YC; Liaw, CW; Liu, SJ; Peng, YJ | 1 |
Kau, YC; Liu, KS; Liu, SJ; Peng, YJ; Wen, CW | 1 |
Bolotin, A; Chapot-Chartier, MP; Courtin, P; Daniel, R; David, B; Deghorain, M; Errington, J; Fontaine, L; Hallet, B; Hols, P; Mainardi, JL; Sorokin, A | 1 |
Liu, F; Liu, J; Ni, B; Wang, F; Zhu, YZ; Zhu, Z | 1 |
Boonen, J; Coenye, T; D'Hondt, M; De Spiegeleer, B; Luyten, J; Mullens, S; Ravelingien, M; Remon, JP; Vervaet, C | 1 |
Chan, EC; Chen, KT; Lee, MS; Lin, SS; Liu, SJ; Ueng, SW; Yuan, LJ | 1 |
Bayramli, E; Dağdeviren, S; Kankilic, B; Kilic, E; Korkusuz, F | 1 |
Abedellatif, B; Barros-Velàzquez, J; Bourouni, OC; Calo-Mata, P; El Bour, M; Mraouna, R | 1 |
Chen, DW; Chen, JK; Hsu, YH; Liao, JY; Liu, SJ; Ueng, SW | 1 |
Amstalden, EM; Coraca-Huber, DC; Duek, EA; Etchebehere, M; Magna, LA | 1 |
Jelvehgari, M; Loveymi, BD; Valizadeh, H; Zakeri-Milani, P | 1 |
Calascibetta, F; Di Stefano, M; Fiorica, C; Giammona, G; Palumbo, FS; Pitarresi, G | 1 |
Chen, WA; Kao, YC; Liao, JY; Liu, SJ; Tseng, YY | 1 |
Argarate, N; Boccaccini, AR; Garmendia, N; Morin, F; Nooeaid, P; Olalde, B; Sáez-Martínez, V | 1 |
Abdollahi, S; Hassan, M; Jelvehgari, M; Lotfipour, F; Milani, M; Valizadeh, H | 1 |
Araya-Kojima, T; Chibazakura, T; Hirose, Y; Satomi, S; Shimizu-Kadota, M; Shiwa, Y; Sonomoto, K; Watanabe, S; Yanase, H; Yoshikawa, H; Zendo, T | 1 |
Chia, WT; Chung, MF; Hsiao, CW; Hsiao, HC; Liu, HY; Sung, HW; Yang, CM | 1 |
Bilgic, E; Kankilic, B; Korkusuz, F; Korkusuz, P | 1 |
Chia, WT; Chiang, WL; Hsiao, HC; Lin, TT; Liu, HY; Sung, HW; Sureshbabu, R; Yang, CM | 1 |
Liu, SJ; Su, CH; Tseng, YY; Wang, YC | 1 |
Cong, Y; Huang, G; Jiang, Q; Liu, J; Liu, M; Quan, C; Tong, G; Yin, Y; Zhang, C | 1 |
Brzychczy-Wloch, M; Pamula, E; Posadowska, U | 1 |
Bayer, E; Fedorchak, M; Jhunjhunwala, S; Kumta, PN; Little, SR; Roy, A | 1 |
Cheng, YS; Chou, YC; Hsu, YH; Liu, SJ; Yu, YH | 1 |
Chen, C; Chen, Q; Ding, Z; Gao, J; Huang, G; Liu, G; Liu, Y; Ren, L | 1 |
Chan, EC; Chou, YC; Hsu, YH; Lin, CT; Liu, SJ; Yu, YH | 1 |
Feng, Q; Hao, Y; Hu, N; Liu, Q; Mi, Z; Wang, Z; Yang, H; Zhu, L | 1 |
Liu, X; Liu, Z; Wu, S; Yeung, KWK; Zhu, Y | 1 |
Chan, EC; Chang, TM; Chou, YC; Hsu, YH; Lee, D; Liu, SJ; Yu, YH | 1 |
Du, L; Feng, S; Li, H; Li, W; Nie, HY; Tu, M; Xiao, L; Yang, S; Yu, B; Zeng, R | 1 |
Desguin, B; Hausinger, RP; Hols, P; Soumillion, P | 1 |
Lee, CH; Lee, D; Liu, KS; Liu, M; Tsai, FC; Tseng, YY | 1 |
Aoki, Y; Bito, S; Hirose, S; Kamimura, Y; Kimura, Y; Mori, N | 1 |
Cunha, GMF; Fialho, SL; Magalhães, JT; Moreira, TP; Patrício, PSO; Pereira, AF; Resende, AFC; Silva, GR; Silva-Cunha, A | 1 |
Chen, G; Huang, J; Li, Z; Liu, Y; Ren, J; Wang, G; Wu, X | 1 |
Bhardwaj, P; Islam, MZ; Kim, C; Nguyen, UT; Palmer, KL | 1 |
Bonvent, JJ; Rosa, JC; Santos, AR | 1 |
Cheng, Y; Gao, H; Meng, L; Qi, D; She, P; Wang, N; Yue, X; Zhao, Y | 1 |
Dincer, E; Kivanc, M | 1 |
Chou, YC; Hsu, YH; Lin, YT; Liu, SJ; Lu, CJ; Ueng, SW; Yu, YH | 1 |
Su, M; Tang, R; Xiao, S; Yi, J; Zhang, Y | 1 |
1 review(s) available for vancomycin and lactic acid
Article | Year |
---|---|
Unexpected complexity in the lactate racemization system of lactic acid bacteria.
Topics: Cell Wall; Gene Expression Regulation, Bacterial; Humans; Lactic Acid; Lactobacillus plantarum; Racemases and Epimerases; Vancomycin; Vancomycin Resistance | 2017 |
65 other study(ies) available for vancomycin and lactic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci.
Topics: Drug Resistance, Microbial; Enterococcus faecium; Lactates; Lactic Acid; Microbial Sensitivity Tests; Peptidoglycan; Vancomycin | 1992 |
d-Lactic acidosis due to abnormal gut flora: diagnosis and treatment of two cases.
Topics: Acidosis; Adult; Bacteria; Feces; Female; Humans; Intestine, Small; Intestines; Lactates; Lactic Acid; Male; Postoperative Complications; Stereoisomerism; Vancomycin | 1982 |
Induction of vancomycin resistance in Enterococcus faecium by non-glycopeptide antibiotics.
Topics: Anti-Bacterial Agents; Antimetabolites; Bacitracin; Cycloserine; Drug Resistance, Microbial; Enterococcus faecium; Lactates; Lactic Acid; Penicillin G; Penicillins; Peptidoglycan; Signal Transduction; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1995 |
The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; Cell Wall; Cloning, Molecular; DNA Transposable Elements; Drug Resistance, Microbial; Enterococcus faecium; Genes, Bacterial; Lactates; Lactic Acid; Molecular Sequence Data; Operon; Peptidoglycan; Teicoplanin; Vancomycin | 1995 |
Knockout of the two ldh genes has a major impact on peptidoglycan precursor synthesis in Lactobacillus plantarum.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Resistance, Microbial; Genes, Bacterial; Glycopeptides; L-Lactate Dehydrogenase; Lactic Acid; Lactobacillus; Mass Spectrometry; Mutagenesis; Peptidoglycan; Teicoplanin; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 1996 |
In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmethacrylate beads.
Topics: Anti-Bacterial Agents; Biodegradation, Environmental; Clindamycin; Delayed-Action Preparations; Diffusion; Drug Implants; Lactic Acid; Methylmethacrylates; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Tobramycin; Vancomycin | 1997 |
Treatment of osteomyelitis with a biodegradable antibiotic implant.
Topics: Animals; Anti-Bacterial Agents; Biodegradation, Environmental; Disease Models, Animal; Drug Delivery Systems; Female; Lactic Acid; Osteomyelitis; Polyesters; Polymers; Rabbits; Staphylococcal Infections; Vancomycin | 1997 |
Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Biodegradation, Environmental; Calcium Sulfate; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Femur; Fluorescence Polarization Immunoassay; Lactic Acid; Materials Testing; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Radiography; Staphylococcal Infections; Vancomycin | 1997 |
A rational strategy for enhancing the affinity of vancomycin towards depsipeptide ligands.
Topics: Alanine; Anti-Bacterial Agents; Dipeptides; Drug Resistance, Microbial; Lactic Acid; Ligands; Models, Molecular; Thermodynamics; Vancomycin | 1998 |
Development of a biodegradable antibiotic delivery system.
Topics: Absorbable Implants; Anti-Bacterial Agents; Biocompatible Materials; Biodegradation, Environmental; Buffers; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Delivery Systems; Drug Resistance, Microbial; Humans; Hydrolysis; Lactic Acid; Microspheres; Phosphates; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Regression Analysis; Sodium Chloride; Staphylococcus aureus; Surface Properties; Surgical Wound Infection; Time Factors; Vancomycin | 1999 |
Vancomycin-resistant enterococci isolates from the rumen content of deer.
Topics: Animals; Anti-Bacterial Agents; Deer; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Lactic Acid; Microbial Sensitivity Tests; Rumen; Urease; Vancomycin | 1999 |
Determinants for differential effects on D-Ala-D-lactate vs D-Ala-D-Ala formation by the VanA ligase from vancomycin-resistant enterococci.
Topics: Adenosine Triphosphatases; Alanine; Amino Acid Sequence; Anti-Bacterial Agents; Arginine; Bacterial Proteins; Base Sequence; Carbon-Oxygen Ligases; Dipeptides; Enterococcus; Enzyme Activation; Histidine; Hydrogen-Ion Concentration; Lactic Acid; Leuconostoc; Ligands; Lysine; Molecular Sequence Data; Mutagenesis, Site-Directed; Peptide Synthases; Stereoisomerism; Templates, Genetic; Vancomycin; Vancomycin Resistance | 1999 |
Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding.
Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Glycine; Lactates; Lactic Acid; Ligands; Models, Molecular; Stereoisomerism; Structure-Activity Relationship; Vancomycin | 1999 |
Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers.
Topics: Alanine; Anti-Bacterial Agents; Binding Sites; Dimerization; Fatty Acids; Hydrogen Bonding; Kinetics; Lactic Acid; Peptides; Peptidoglycan; Phosphatidylcholines; Protein Binding; Surface Plasmon Resonance; Vancomycin | 2000 |
Confusion after antibiotics.
Topics: Acidosis, Lactic; Anti-Bacterial Agents; Confusion; Female; Humans; Lactic Acid; Lacticaseibacillus casei; Middle Aged; Neomycin; Parenteral Nutrition, Home Total; Vancomycin | 2001 |
Lactoferrin-induced reduction of vanB vancomycin resistance in enterococci.
Topics: Cell Wall; Culture Media; Drug Resistance, Bacterial; Enterococcus faecium; Lactic Acid; Lactoferrin; Microbial Sensitivity Tests; Vancomycin | 2001 |
PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies.
Topics: Animals; Aqueous Humor; Drug Delivery Systems; Emulsifying Agents; Lactic Acid; Male; Microspheres; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Vancomycin | 2004 |
Implantation of vancomycin microspheres in blend with human/rabbit bone grafts to infected bone defects.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biocompatible Materials; Bone Transplantation; Drug Compounding; Drug Implants; Humans; Lactic Acid; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Microspheres; Osteomyelitis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Staphylococcal Infections; Surface Properties; Synovial Fluid; Vancomycin | 2006 |
Novel solvent-free fabrication of biodegradable poly-lactic-glycolic acid (PLGA) capsules for antibiotics and rhBMP-2 delivery.
Topics: Animals; Anti-Bacterial Agents; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Capsules; Delayed-Action Preparations; Enzyme-Linked Immunosorbent Assay; Glycolates; Humans; Lactic Acid; Microbial Sensitivity Tests; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Recombinant Proteins; Staphylococcus aureus; Technology, Pharmaceutical; Transforming Growth Factor beta; Vancomycin | 2007 |
In vitro efficacy of newly designed vancomycin-based microparticles.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Adhesion; Biocompatible Materials; Colony Count, Microbial; Drug Carriers; Endophthalmitis; Lactic Acid; Lenses, Intraocular; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Staphylococcus epidermidis; Vancomycin | 2007 |
Selectivity for D-lactate incorporation into the peptidoglycan precursors of Lactobacillus plantarum: role of Aad, a VanX-like D-alanyl-D-alanine dipeptidase.
Topics: Bacterial Proteins; Biological Transport; Dipeptidases; Lactic Acid; Lactobacillus plantarum; Microscopy, Fluorescence; Models, Biological; Peptidoglycan; Vancomycin | 2007 |
Electrokinetic partial filling technique as a powerful tool for enantiomeric separation of DL-lactic acid by CE with contactless conductivity detection.
Topics: Countercurrent Distribution; Electric Conductivity; Electrophoresis, Capillary; Lactic Acid; Stereoisomerism; Vancomycin | 2007 |
An ionically crosslinked hydrogel containing vancomycin coating on a porous scaffold for drug delivery and cell culture.
Topics: Alginates; Animals; Calcium Phosphates; Cell Line; Cell Survival; Compressive Strength; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Lactic Acid; Polyesters; Polymers; Porosity; Rats; Solubility; Vancomycin; Wettability | 2008 |
Inhibition of vancomycin and high-level aminoglycoside-resistant enterococci strains and Listeria monocytogenes by bacteriocin-like substance produced by Enterococcus faecium E86.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacteriocins; Drug Resistance, Bacterial; Enterococcus faecium; Food Microbiology; Lactic Acid; Vancomycin | 2008 |
In vitro elution of vancomycin/amikacin/steroid from solvent-free biodegradable scleral plugs.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Drug Stability; Drug Therapy, Combination; Endophthalmitis; Escherichia coli; Glucocorticoids; Lactic Acid; Microbial Sensitivity Tests; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sclera; Staphylococcus aureus; Vancomycin | 2009 |
Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone--an in vivo study.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biocompatible Materials; Dexamethasone; Drug Carriers; Drug Delivery Systems; Endophthalmitis; Lactic Acid; Materials Testing; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Rabbits; Sclera; Solvents; Vancomycin | 2010 |
Functional and morphological adaptation to peptidoglycan precursor alteration in Lactococcus lactis.
Topics: Anti-Bacterial Agents; Cell Proliferation; Cell Wall; Drug Resistance, Microbial; Genome; Lactic Acid; Lactococcus lactis; Methicillin; Models, Biological; Mutation; Penicillin-Binding Proteins; Peptidoglycan; Plasmids; Sequence Analysis, DNA; Vancomycin | 2010 |
Intra-discal vancomycin-loaded PLGA microsphere injection for MRSA discitis: an experimental study.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Discitis; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Microspheres; Polyesters; Polymers; Rabbits; Staphylococcal Infections; Vancomycin | 2011 |
Vancomycin release from poly(D,L-lactic acid) spray-coated hydroxyapatite fibers.
Topics: Anti-Bacterial Agents; Coated Materials, Biocompatible; Drug Delivery Systems; Durapatite; Lactic Acid; Materials Testing; Methicillin-Resistant Staphylococcus aureus; Polyesters; Polymers; Porosity; Vancomycin | 2010 |
In vitro and in vivo analysis of a biodegradable poly(lactide-co-glycolide) copolymer capsule and collagen composite system for antibiotics and bone cells delivery.
Topics: Alkaline Phosphatase; Animals; Biocompatible Materials; Bone and Bones; Calcium; Capsules; Cells, Cultured; Chromatography, High Pressure Liquid; Collagen; Drug Carriers; Drug Delivery Systems; Femur; In Vitro Techniques; Lactic Acid; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Microbial Sensitivity Tests; Microscopy, Fluorescence; Osteogenesis; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Staining and Labeling; Vancomycin | 2011 |
Vancomycin containing PLLA/β-TCP controls MRSA in vitro.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Bone Substitutes; Calcium Phosphates; Cell Adhesion; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteosarcoma; Polyesters; Polymers; Staphylococcal Infections; Vancomycin | 2011 |
Phylogenetic analysis of antimicrobial lactic acid bacteria from farmed seabass Dicentrarchus labrax.
Topics: Animals; Anti-Bacterial Agents; Aquaculture; Bacteria; Base Sequence; Bass; Enterococcus; Humans; Lactic Acid; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Seafood; Vancomycin; Vancomycin Resistance | 2012 |
Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes.
Topics: Anesthetics, Local; Anti-Bacterial Agents; Cell Adhesion; Cell Survival; Cells, Cultured; Chemistry, Pharmaceutical; Child, Preschool; Chromatography, High Pressure Liquid; Collagen; Delayed-Action Preparations; Disk Diffusion Antimicrobial Tests; Drug Carriers; Drug Compounding; Drug Stability; Escherichia coli; Fibroblasts; Gentamicins; Humans; Infant; Kinetics; Lactic Acid; Lidocaine; Membranes, Artificial; Microbial Sensitivity Tests; Nanofibers; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Propanols; Solubility; Solvents; Staphylococcus aureus; Technology, Pharmaceutical; Vancomycin | 2012 |
The use of vancomycin-loaded poly-l-lactic acid and poly-ethylene oxide microspheres for bone repair: an in vivo study.
Topics: Animals; Biocompatible Materials; Bone Substitutes; Lactic Acid; Male; Microspheres; Osteogenesis; Polyesters; Polyethylene Glycols; Polymers; Rats; Rats, Wistar; Tibial Fractures; Time Factors; Vancomycin | 2012 |
The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system.
Topics: Animals; Calorimetry, Differential Scanning; Colloids; Drug Delivery Systems; Intestinal Absorption; Lactic Acid; Male; Nanoparticles; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Vancomycin; X-Ray Diffraction | 2013 |
Medicated hydrogels of hyaluronic acid derivatives for use in orthopedic field.
Topics: Anti-Bacterial Agents; Cells, Cultured; Femur; Fibroblasts; Humans; Hyaluronic Acid; Hydrogels; Lactic Acid; Orthopedic Procedures; Polyesters; Polyethylene Glycols; Polymers; Prosthesis Design; Prosthesis-Related Infections; Rheology; Skin; Sterilization; Titanium; Tobramycin; Vancomycin | 2013 |
Biodegradable drug-eluting poly[lactic-co-glycol acid] nanofibers for the sustainable delivery of vancomycin to brain tissue: in vitro and in vivo studies.
Topics: Absorbable Implants; Absorption; Animals; Anti-Bacterial Agents; Brain; Brain Abscess; Chromatography, High Pressure Liquid; Combined Modality Therapy; Drug Carriers; Drug Evaluation, Preclinical; Drug Implants; Lactic Acid; Membranes, Artificial; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Random Allocation; Rats; Vancomycin; Wound Healing | 2013 |
Multifunctional bioactive glass scaffolds coated with layers of poly(D,L-lactide-co-glycolide) and poly(n-isopropylacrylamide-co-acrylic acid) microgels loaded with vancomycin.
Topics: Acrylamides; Calcium; Coated Materials, Biocompatible; Gels; Glass; Lactic Acid; Microscopy, Electron, Scanning; Minerals; Phosphorus; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared; Tissue Scaffolds; Vancomycin | 2013 |
Study of antimicrobial effects of vancomycin loaded PLGA nanoparticles against enterococcus clinical isolates.
Topics: Anti-Infective Agents; Drug Carriers; Enterococcus; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vancomycin | 2014 |
Complete genome sequence of Enterococcus mundtii QU 25, an efficient L-(+)-lactic acid-producing bacterium.
Topics: Anti-Bacterial Agents; Bacteriocins; Base Sequence; Drug Resistance, Bacterial; Enterococcus; Fermentation; Genome, Bacterial; Hemolysin Proteins; Interspersed Repetitive Sequences; Lactic Acid; Molecular Sequence Data; Multigene Family; Phylogeny; Plasmids; Sequence Analysis, DNA; Vancomycin | 2014 |
Inflammation-induced drug release by using a pH-responsive gas-generating hollow-microsphere system for the treatment of osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Carbon Dioxide; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Gases; Hydrogen-Ion Concentration; Inflammation; Lactic Acid; Microspheres; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Vancomycin | 2014 |
Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.
Topics: Animals; Bone Development; Bone-Implant Interface; Calcium Phosphates; Lactic Acid; Male; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Polyesters; Polymers; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Tibia; Tissue Scaffolds; Vancomycin | 2014 |
A rapid drug release system with a NIR light-activated molecular switch for dual-modality photothermal/antibiotic treatments of subcutaneous abscesses.
Topics: Abscess; Animals; Anti-Bacterial Agents; Drug Delivery Systems; Hot Temperature; Infrared Rays; Injections, Subcutaneous; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microspheres; Nanoparticles; Photochemistry; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrroles; Skin Diseases; Tissue Distribution; Vancomycin; Wound Healing | 2015 |
Biodegradable vancomycin-eluting poly[(d,l)-lactide-co-glycolide] nanofibres for the treatment of postoperative central nervous system infection.
Topics: Animals; Anti-Bacterial Agents; Brain; Central Nervous System Infections; Drug Carriers; Kaplan-Meier Estimate; Lactic Acid; Magnetic Resonance Imaging; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Postoperative Complications; Radiography; Rats; Rats, Wistar; Vancomycin | 2015 |
Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
Topics: Alendronate; Animals; Anti-Bacterial Agents; Bone and Bones; Cell Line; Cell Line, Tumor; Drug Carriers; Drug Liberation; Durapatite; Humans; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Micelles; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Rats; Vancomycin | 2015 |
Injectable gellan gum-based nanoparticles-loaded system for the local delivery of vancomycin in osteomyelitis treatment.
Topics: Anti-Bacterial Agents; Cell Line; Cell Survival; Humans; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Osteoblasts; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polysaccharides, Bacterial; Staphylococcus; Vancomycin | 2016 |
Porous calcium phosphate-poly (lactic-co-glycolic) acid composite bone cement: A viable tunable drug delivery system.
Topics: Bone Cements; Calcium Phosphates; Drug Delivery Systems; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Vancomycin | 2016 |
A bio-artificial poly([D,L]-lactide-co-glycolide) drug-eluting nanofibrous periosteum for segmental long bone open fractures with significant periosteal stripping injuries.
Topics: Animals; Ceftazidime; Drug Carriers; Femoral Fractures; Fractures, Open; Lactic Acid; Lidocaine; Membranes, Artificial; Nanofibers; Periosteum; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Vancomycin | 2016 |
A biodegradable antibiotic-eluting PLGA nanofiber-loaded deproteinized bone for treatment of infected rabbit bone defects.
Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Bacterial Load; Bone and Bones; Bone Diseases, Infectious; Bone Regeneration; Cattle; Chromatography, High Pressure Liquid; Drug Carriers; Drug Liberation; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Random Allocation; Tissue Scaffolds; Vancomycin | 2016 |
Dual delivery of active antibactericidal agents and bone morphogenetic protein at sustainable high concentrations using biodegradable sheath-core-structured drug-eluting nanofibers.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Morphogenetic Protein 2; Ceftazidime; Drug Delivery Systems; Drug Liberation; Humans; Lactic Acid; Microbial Sensitivity Tests; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Tensile Strength; Vancomycin; Water | 2016 |
Preparation and in vitro study of hydrochloric norvancomycin encapsulated poly (d,l-lactide-co-glycolide, PLGA) microspheres for potential use in osteomyelitis.
Topics: Capsules; Drug Carriers; Drug Liberation; Lactic Acid; Microspheres; Oils; Osteomyelitis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vancomycin; Water | 2017 |
Construction of poly (vinyl alcohol)/poly (lactide-glycolide acid)/vancomycin nanoparticles on titanium for enhancing the surface self-antibacterial activity and cytocompatibility.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Cell Proliferation; Cell Survival; Drug Carriers; Drug Delivery Systems; Emulsions; Hydrogen-Ion Concentration; Hydrolysis; Lactic Acid; Mice; Nanoparticles; Osteoblasts; Polyglycolic Acid; Polyvinyl Alcohol; Propylamines; Prostheses and Implants; Silanes; Spectroscopy, Fourier Transform Infrared; Surface Properties; Titanium; Vancomycin | 2017 |
Combination of a biodegradable three-dimensional (3D) - printed cage for mechanical support and nanofibrous membranes for sustainable release of antimicrobial agents for treating the femoral metaphyseal comminuted fracture.
Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Ceftazidime; Femoral Fractures; Fractures, Comminuted; Lactic Acid; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Tissue Scaffolds; Vancomycin | 2017 |
Scaffold composed of porous vancomycin-loaded poly(lactide-co-glycolide) microspheres: A controlled-release drug delivery system with shape-memory effect.
Topics: Delayed-Action Preparations; Drug Delivery Systems; Lactic Acid; Microspheres; Polyglactin 910; Polyglycolic Acid; Porosity; Tissue Scaffolds; Vancomycin | 2017 |
Sustained local delivery of high-concentration vancomycin from a hybrid biodegradable, antibiotic-eluting, nanofiber-loaded endovascular prosthesis for treatment of mycotic aortic aneurysms.
Topics: Absorbable Implants; Aneurysm, Infected; Animals; Anti-Bacterial Agents; Aorta, Abdominal; Aortic Aneurysm; Aortography; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Computed Tomography Angiography; Delayed-Action Preparations; Drug Implants; Drug Liberation; Endovascular Procedures; Humans; Lactic Acid; Male; Models, Anatomic; Models, Animal; Models, Cardiovascular; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Printing, Three-Dimensional; Prosthesis Design; Rabbits; Vancomycin | 2018 |
Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case-control studies of incidence and associated risk factors.
Topics: Acid-Base Equilibrium; Acidosis, Lactic; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biomarkers; Chi-Square Distribution; Comorbidity; Female; Humans; Incidence; Lactic Acid; Linezolid; Male; Middle Aged; Odds Ratio; Prognosis; Propensity Score; Renal Insufficiency; Retrospective Studies; Risk Factors; Vancomycin | 2018 |
PLGA Implants containing vancomycin and dexamethasone: development, characterization and bactericidal effects.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteria; Dexamethasone; Drug Carriers; Drug Implants; Drug Liberation; Endophthalmitis; Humans; Lactic Acid; Microbial Sensitivity Tests; Ophthalmologic Surgical Procedures; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcus aureus; Staphylococcus epidermidis; Surgical Wound Infection; Vancomycin | 2016 |
Tunable sequential drug delivery system based on chitosan/hyaluronic acid hydrogels and PLGA microspheres for management of non-healing infected wounds.
Topics: Animals; Bacteria; Biocompatible Materials; Cell Proliferation; Chitosan; Cytokines; Drug Carriers; Drug Liberation; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronic Acid; Hydrogels; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rats; Skin Diseases; Vancomycin; Vascular Endothelial Growth Factor A; Wound Healing | 2018 |
ddcP, pstB, and excess D-lactate impact synergism between vancomycin and chlorhexidine against Enterococcus faecium 1,231,410.
Topics: Adenosine Triphosphatases; Anti-Bacterial Agents; Anti-Infective Agents, Local; ATP-Binding Cassette Transporters; Bacterial Proteins; Chlorhexidine; Drug Synergism; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Lactic Acid; Vancomycin | 2021 |
Poly (ε-caprolactone)/Poly (lactic acid) fibers produced by rotary jet spinning for skin dressing with antimicrobial activity.
Topics: Anti-Infective Agents; Bandages; Humans; Lactic Acid; Nanofibers; Polyesters; Polymers; Tissue Scaffolds; Vancomycin | 2022 |
Application of Porous Polyetheretherketone Scaffold/Vancomycin-Loaded Thermosensitive Hydrogel Composites for Antibacterial Therapy in Bone Repair.
Topics: Anti-Bacterial Agents; Benzophenones; Biocompatible Materials; Delayed-Action Preparations; Glycolates; Hydrogels; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Polyethylene Glycols; Polymers; Porosity; Vancomycin | 2022 |
Evaluation of metabolic activities and probiotic characteristics of two Latilactobacillus sakei strains isolated from pastırma.
Topics: Animals; Anti-Bacterial Agents; Bacteriocins; Cattle; Chloramphenicol; Hydrogen Peroxide; Lactic Acid; Latilactobacillus sakei; Netilmicin; Probiotics; Tetracyclines; Vancomycin | 2022 |
Sustained Release of Antifungal and Antibacterial Agents from Novel Hybrid Degradable Nanofibers for the Treatment of Polymicrobial Osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Ceftazidime; Delayed-Action Preparations; Fluconazole; Lactic Acid; Nanofibers; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Vancomycin | 2023 |
Mitigating Lactate-Associated Immunosuppression against Intracellular Bacteria Using Thermoresponsive Nanoparticles for Septic Arthritis Therapy.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Bacteria; Humans; Immunosuppression Therapy; Lactic Acid; Nanoparticles; Oxygen; Reactive Oxygen Species; Vancomycin | 2023 |